Ruptured Aorta-iliac Aneurysms: Endo vs. Surgery (ECAR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00577616 |
Recruitment Status :
Completed
First Posted : December 20, 2007
Last Update Posted : October 23, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ruptured Aorta-iliac Aneurysms | Procedure: Endovascular repair | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 107 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Study Comparing Endovascular Repair Versus Conventional Repair for Ruptured Aorta-iliac Aneurysms |
Study Start Date : | December 2007 |
Actual Primary Completion Date : | February 2013 |
Actual Study Completion Date : | February 2014 |
Arm | Intervention/treatment |
---|---|
1
Endovascular repair
|
Procedure: Endovascular repair
Endovascular repair of the asymptomatic aneurysms of the abdominal aorta |
2
conventional surgery repair
|
Procedure: Endovascular repair
Endovascular repair of the asymptomatic aneurysms of the abdominal aorta |
- Mortality at 30 days after the treatment(endovascular repair versus conventional repair) [ Time Frame: 30 days after the treatment ]
- Compare at 30 days after the treatment the:- Cardiac , pulmonary, digestive , renal neurological morbidity, other…- Duration of stay in intensive care unit- Quantity of blood transfusions [ Time Frame: 30 days after the treatment ]
- Compare at 6 month after the treatment the:- Cardiac , pulmonary, digestive , renal neurological morbidity (amendment 6) [ Time Frame: 6 month after treatment ]
- Compare at one year after the treatment the:- Cardiac , pulmonary, digestive , renal neurological morbidity (amendment 6) [ Time Frame: one year after the treatment ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age >= 18 years
- Ruptured aorta-iliac aneurysms diagnosed by CT
- scan with injection.
-
Aneurysm developed on native infra-renal aorta or iliac.
- Non infectious false aneurysms developed on prosthesis (Deleted by amendment n°1 at the request of AFSSAPS)
- Ruptured aneurysm after endoprosthesis (Deleted by amendment n°1 at the request of AFSSAPS)
- Stable hemodynamic condition: systolic blood pressure on arrival higher than 80 mmHg in the absence of continuous vasopressive drugs administration.
- Anatomic criteria :length of aortic proximal neck >10 mm, diameter of aortic proximal neck < 32 mm, Absence of aortic neck angulation > 90° and patent iliac without important stenosis or tortuosity.
- Technical constraints (validation of experience form) : Trained operator (at least 15 endoprosthesis in asymptomatic patients), Endovascular materials at disposal
Exclusion Criteria:
- Unstable hemodynamic condition
- Anatomic criteria of non-inclusion
- Asymptomatic aneurysm
- Non-ruptured symptomatic aneurysm or aneurysm complicated with emboli.
- Mycotic aneurysm, infectious false aneurysms
- Post-traumatic aneurysm
- Supra-renal thoracic-abdominal aneurysm
- Impossibility to obtain a CT-scan with injection
- Patient non-affiliated to the social security and the protected people
- Pregnancy or breast-feeding

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00577616
France | |
CHU Henri Mondor | |
Creteil, France, 94000 |
Principal Investigator: | Pascal Desgranges, PUPH | Assistance Publique - Hôpitaux de Paris |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT00577616 |
Other Study ID Numbers: |
AOM06055 K060216 |
First Posted: | December 20, 2007 Key Record Dates |
Last Update Posted: | October 23, 2014 |
Last Verified: | July 2013 |
Endovascular repair Ruptured aorta-iliac aneurysms Mortality at 30 days |
Aneurysm Iliac Aneurysm Vascular Diseases Cardiovascular Diseases |